Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Edwards Lifesciences Corp (NYSE:EW)

114.44
Delayed Data
As of Jul 27
 +6.09 / +5.62%
Today’s Change
62.53
Today|||52-Week Range
117.46
+44.90%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Operating ActivitiesNet Income / Starting Line112.7M118.1M140.7M143.0M
 
 
 
 
 
Depreciation16.8M18.5M14.5M15.9M
 
 
 
 
 
Total Other Cash Flow1.5M13.3M2.3M3.6M
 
 
 
 
 
Funds From Operations129.1M146.6M63.6M162.7M
 
 
 
 
 
Funds From/For Other Operating Expenses-41.0M-55.9M-40.2M55.6M
 
 
 
 
 
Net Cash Flow - Operating Activities170.1M202.5M103.8M107.1M
 
 
 
 
 
 
InvestingIncrease In Investments-255.8M-453.0M-105.3M-231.9M
 
 
 
 
 
Decrease In Investments292.1M620.1M181.3M302.7M
 
 
 
 
 
Capital Expenditures-18.4M-26.0M-37.5M-27.7M
 
 
 
 
 
Net Assets From Acquisitions -----11.5M0.00
 
 
Other Investing - Uses-5.1M3.4M1.7M0.00
 
 
 
 
Other Investing - Sources-300.0K0.00--4.2M
 
 
 
Net Cash Flow Investing12.5M-175.6M27.3M47.3M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings5.9M7.4M10.7M9.7M
 
 
 
 
 
Long Term Debt Reduction-6.5M-4.1M-10.7M-9.5M
 
 
 
 
 
Net Proceeds Stock Sale19.0M17.5M27.2M19.5M
 
 
 
 
 
Common Preferred Redeemed-78.9M-200.0K-100.0M-344.1M
 
 
 
 
 
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing9.9M7.4M14.2M12.8M
 
 
 
 
 
Other Uses - Financing0.004.4M1.1M57.5M
 
 
 
 
Net Cash Flow - Financing-50.6M23.6M-59.7M-369.1M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash8.6M-2.0M900.0K-2.3M
 
 
 
 
 
 
Net Change In Cash132.0M50.5M71.4M-214.7M